文献速递心境障碍

探究正念认知疗法(MBCT)对复发性抑郁症的起效机制:PREVENT 试验中的调节中介分析

Examining what works for whom and how in mindfulness-based cognitive therapy (MBCT) for recurrent depression: moderated-mediation analysis in the PREVENT trial.
PubMed 文献 · Br J Psychiatry · 2024-11-08

基于 PREVENT 试验数据,纳入 424 名既往至少 3 次抑郁发作、处于完全或部分缓解期且正在服用抗抑郁药的英国成人,比较正念认知疗法(MBCT)联合减药支持与维持抗抑郁药治疗。发现正念技能在分组与 24 个月抑郁症状线性变化率之间起中介作用,且该中介效应受基线抑郁严重度调节,高严重度者条件间接效应为 -0.42(95% CI -0.78, -0.18),低严重度者为 -0.15(95% CI -0.35, -0.02)。

要点

  • 在复发性抑郁症缓解期患者中,正念技能是 MBCT(对比维持抗抑郁药)起效的中介机制。
  • 中介效应受基线抑郁严重度调节,高严重度者条件间接效应为 -0.42(95% CI -0.78, -0.18)。
  • 高抑郁严重度个体可能从 MBCT 联合减药支持中获益最大,针对残留症状。

核心结论

  • 正念技能是驱动 MBCT(对比维持抗抑郁药)起效的独特机制。
  • 抑郁严重度较高的个体可能从 MBCT 联合减药支持中最大程度获益,针对残留症状。
  • 这些效应是否适用于当前抑郁发作的个体尚不清楚。
  • 未来研究应调查未服用抗抑郁药的个体。
  • 本研究为复发性抑郁症的个体化管理提供了初步证据。

研究设计与样本

  • 基于 PREVENT(预防抑郁复发或再发)试验数据,比较 MBCT 联合抗抑郁药减药支持与维持抗抑郁药治疗。
  • 纳入标准为既往至少 3 次重性抑郁发作、处于完全或部分缓解(低于当前发作阈值)、正在服用抗抑郁药的成人,在英国初级保健诊所评估资格。
  • 参与者按 1:1 随机分配至 MBCT 联合减药支持组或维持抗抑郁药组。
  • 评估时间点为治疗前、治疗后、9、12、18 和 24 个月随访。
  • 采用贝克抑郁量表-II(BDI-II)在六个时间点评估抑郁症状变化,采用五因素正念问卷在治疗前后评估正念技能,并运用潜在剖面调节中介增长混合模型进行分析。

主要发现

  • 共纳入 424 人,平均年龄 49.44 岁(标准差 12.31),其中 325 人(76.7%)自我认同为女性。
  • 正念技能在分组与 24 个月抑郁症状线性变化率之间的中介效应受抑郁严重度调节,调节中介指数为 -0.27(95% CI -0.66, -0.03)。
  • 高严重度组(预期 BDI-II 平均降低 10 分)的条件间接效应为 -0.42(95% CI -0.78, -0.18)。
  • 低严重度组(预期 BDI-II 平均降低 3.5 分)的条件间接效应为 -0.15(95% CI -0.35, -0.02)。

临床怎么用

  • 作者认为,抑郁严重度较高的个体可能从 MBCT 联合减药支持中最大程度获益,针对残留症状。
  • 作者指出,这些效应是否适用于当前抑郁发作的个体尚不清楚。
  • 作者建议,未来研究应调查未服用抗抑郁药的个体。
  • 作者认为,本研究为复发性抑郁症的个体化管理提供了初步证据。

局限性

  • 这些效应是否适用于当前抑郁发作的个体尚不清楚。
  • 未来研究应调查未服用抗抑郁药的个体。
  • 本研究为个体化管理提供的证据为初步证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Personalised management of recurrent depression, considering individual patient characteristics, is crucial. AIMS: This study evaluates the potentially different mediating role of mindfulness skills in managing recurrent depression using mindfulness-based cognitive therapy (MBCT) among people with varying depression severity. METHOD: Data from the Prevention of Depressive Relapse or Recurrence (PREVENT) trial, comparing MBCT (with antidepressant medication (ADM) tapering support, MBCT-tapering support) versus maintenance-ADM, were used. The study included pre, post, 9-, 12-, 18- and 24-month follow-ups. Adults with ≥3 previous major depressive episodes, in full/partial remission (below threshold for a current episode), on ADM, were assessed for eligibility in primary care practices in the UK. People were randomised (1:1) to MBCT-tapering support or maintenance-ADM. We used the Beck Depression Inventory-II to evaluate depressive symptom changes over the six time points. Pre-post treatment, we employed the Five Facets of Mindfulness Questionnaire to gauge mindfulness skills. Baseline symptom and history variables were used to identify individuals with varying severity profiles. We conducted Latent Profile Moderated-Mediation Growth Mixture Models. RESULTS: A total of 424 people (mean (s.d.) age = 49.44 (12.31) years; with 325 (76.7%) self-identified as female) were included. A mediating effect of mindfulness skills, between trial arm allocation and the linear rate of depressive symptoms change over 24 months, moderated by depression severity, was observed (moderated-mediation index = -0.27, 95% CI = -0.66, -0.03). Conditional indirect effects were -0.42 (95% CI = -0.78, -0.18) for higher severity (expected mean BDI-II reduction = 10 points), and -0.15 (95% CI = -0.35, -0.02) for lower severity (expected mean BDI-II reduction = 3.5 points). CONCLUSIONS: Mindfulness skills constitute a unique mechanism driving change in MBCT (versus maintenance-ADM). Individuals with higher depression severity may benefit most from MBCT-tapering support for residual symptoms. It is unclear if these effects apply to those with a current depressive episode. Future research should investigate individuals who are not on medication. This study provides preliminary evidence for personalised management of recurrent depression. TRIAL REGISTRATION: ISRCTN26666654.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Montero-Marin J, Hinze V, Maloney S, et al. Examining what works for whom and how in mindfulness-based cognitive therapy (MBCT) for recurrent depression: moderated-mediation analysis in the PREVENT trial. Br J Psychiatry. 2024. PMID: 39512158. doi:10.1192/bjp.2024.178

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。